A San Francisco biotech firm unveils a medication that promises to extend the lifespan of large breed dogs, sparking both excitement and ethical concerns.
A drug that aims to increase life expectancy for dogs is getting closer to market. But pet ethicists aren’t sure it’s great news for man’s best friend.
This episode was produced by Amanda Lewellyn, edited by Matt Collette, fact-checked by Laura Bullard, engineered by David Herman, and hosted by Noel King.